 | • レポートコード：QFJ1-4859 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、エビ病気診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（WSSV（白斑症候群ウイルス）、TSV（タウラ症候群ウイルス）、YHV / GAV（黄頭/鰓関連ウイルス）、IHHNV（感染性皮下・造血器ウイルス）、HPV（肝膵臓パルボウイルス）、MBV（モノドンバキュロウイルス）、IMNV（感染性筋壊死ウイルス）、NHP-B（壊死性肝膵炎細菌）、MoV（ムーリリアンウイルス）、早期死亡症候群（EMS））、用途別市場規模（水産、水産養殖研究所、海洋研究所、教育研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・エビ病気診断の市場動向 ・企業の競争状況、市場シェア ・エビ病気診断の種類別市場規模と予測2016-2027（WSSV（白斑症候群ウイルス）、TSV（タウラ症候群ウイルス）、YHV / GAV（黄頭/鰓関連ウイルス）、IHHNV（感染性皮下・造血器ウイルス）、HPV（肝膵臓パルボウイルス）、MBV（モノドンバキュロウイルス）、IMNV（感染性筋壊死ウイルス）、NHP-B（壊死性肝膵炎細菌）、MoV（ムーリリアンウイルス）、早期死亡症候群（EMS）） ・エビ病気診断の用途別市場規模と予測2016-2027（水産、水産養殖研究所、海洋研究所、教育研究所、その他） ・エビ病気診断の北米市場規模2016-2027（アメリカ、カナダ） ・エビ病気診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・エビ病気診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エビ病気診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・エビ病気診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（HiMedia Laboratories、Speedy Assay Sdn Bhd、REAGEN LLC、FUJIKURA KASEI CO., LTD、GeneReach Biotechnology Corp、Thermo Fisher Scientific、Lab - Ind Resource Sdn Bhd、AquaBounty Technologies, Inc、pop bio、SUREBIO、Auro Biotechnologies） ・結論 |
Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.
Disease problems in shrimp production are poorly understood and diagnosed. Various shrimps diseases such as white spot diseases highly affect shrimp production and continue to pose a serious challenge. Diagnosis of that disease is very important. There is no therapeutic option available for viral diseases and the only option available to detect and avoid the pathogen entry into culture systems. DNA based diagnostic tool such as PCR used to test. Diagnosis tools and technologies are gaining demand for the quick and effective diagnosis of shrimp diseases for management of disease outbreaks. Assay based kits and rapid test kits are available for the shrimp’s disease diagnostic market.
Market Analysis and Insights: Global Shrimps Disease Diagnostic Market
The global Shrimps Disease Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Shrimps Disease Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Shrimps Disease Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Shrimps Disease Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Shrimps Disease Diagnostic market.
Global Shrimps Disease Diagnostic Scope and Market Size
Shrimps Disease Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Shrimps Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)
Segment by Application
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
HiMedia Laboratories
Speedy Assay Sdn Bhd
REAGEN LLC
FUJIKURA KASEI CO., LTD
GeneReach Biotechnology Corp
Thermo Fisher Scientific
Lab – Ind Resource Sdn Bhd
AquaBounty Technologies, Inc
pop bio
SUREBIO
Auro Biotechnologies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Shrimps Disease Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 WSSV (White Spot Syndrome Virus)
1.2.3 TSV (Taura Syndrome Virus)
1.2.4 YHV/GAV (Yellow Head/Gill Associated Virus)
1.2.5 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
1.2.6 HPV (Hepatopancreatic Parvovirus)
1.2.7 MBV (Monodon Baculovirus)
1.2.8 IMNV (Infectious Myonecrosis Virus)
1.2.9 NHP-B (Necrotising Hepatopancreatitis Bacteria)
1.2.10 MoV (Mourilyan Virus)
1.2.11 Early Mortality Syndrome (EMS)
1.3 Market by Application
1.3.1 Global Shrimps Disease Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Fisheries
1.3.3 Aquaculture Laboratories
1.3.4 Marine Laboratories
1.3.5 Education and Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Shrimps Disease Diagnostic Market Perspective (2016-2027)
2.2 Shrimps Disease Diagnostic Growth Trends by Regions
2.2.1 Shrimps Disease Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Shrimps Disease Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Shrimps Disease Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Shrimps Disease Diagnostic Industry Dynamic
2.3.1 Shrimps Disease Diagnostic Market Trends
2.3.2 Shrimps Disease Diagnostic Market Drivers
2.3.3 Shrimps Disease Diagnostic Market Challenges
2.3.4 Shrimps Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Shrimps Disease Diagnostic Players by Revenue
3.1.1 Global Top Shrimps Disease Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Shrimps Disease Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Shrimps Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Shrimps Disease Diagnostic Revenue
3.4 Global Shrimps Disease Diagnostic Market Concentration Ratio
3.4.1 Global Shrimps Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Shrimps Disease Diagnostic Revenue in 2020
3.5 Shrimps Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Shrimps Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Shrimps Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Shrimps Disease Diagnostic Breakdown Data by Type
4.1 Global Shrimps Disease Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Shrimps Disease Diagnostic Forecasted Market Size by Type (2022-2027)
5 Shrimps Disease Diagnostic Breakdown Data by Application
5.1 Global Shrimps Disease Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Shrimps Disease Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Shrimps Disease Diagnostic Market Size (2016-2027)
6.2 North America Shrimps Disease Diagnostic Market Size by Type
6.2.1 North America Shrimps Disease Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Shrimps Disease Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Shrimps Disease Diagnostic Market Size by Type (2016-2027)
6.3 North America Shrimps Disease Diagnostic Market Size by Application
6.3.1 North America Shrimps Disease Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Shrimps Disease Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Shrimps Disease Diagnostic Market Size by Application (2016-2027)
6.4 North America Shrimps Disease Diagnostic Market Size by Country
6.4.1 North America Shrimps Disease Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Shrimps Disease Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Shrimps Disease Diagnostic Market Size (2016-2027)
7.2 Europe Shrimps Disease Diagnostic Market Size by Type
7.2.1 Europe Shrimps Disease Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Shrimps Disease Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Shrimps Disease Diagnostic Market Size by Type (2016-2027)
7.3 Europe Shrimps Disease Diagnostic Market Size by Application
7.3.1 Europe Shrimps Disease Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Shrimps Disease Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Shrimps Disease Diagnostic Market Size by Application (2016-2027)
7.4 Europe Shrimps Disease Diagnostic Market Size by Country
7.4.1 Europe Shrimps Disease Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Shrimps Disease Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Shrimps Disease Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Shrimps Disease Diagnostic Market Size by Type
8.2.1 Asia-Pacific Shrimps Disease Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Shrimps Disease Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Shrimps Disease Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Shrimps Disease Diagnostic Market Size by Application
8.3.1 Asia-Pacific Shrimps Disease Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Shrimps Disease Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Shrimps Disease Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Shrimps Disease Diagnostic Market Size by Region
8.4.1 Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Shrimps Disease Diagnostic Market Size (2016-2027)
9.2 Latin America Shrimps Disease Diagnostic Market Size by Type
9.2.1 Latin America Shrimps Disease Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Shrimps Disease Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Shrimps Disease Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Shrimps Disease Diagnostic Market Size by Application
9.3.1 Latin America Shrimps Disease Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Shrimps Disease Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Shrimps Disease Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Shrimps Disease Diagnostic Market Size by Country
9.4.1 Latin America Shrimps Disease Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Shrimps Disease Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Shrimps Disease Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Shrimps Disease Diagnostic Market Size by Type
10.2.1 Middle East & Africa Shrimps Disease Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Shrimps Disease Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Shrimps Disease Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Shrimps Disease Diagnostic Market Size by Application
10.3.1 Middle East & Africa Shrimps Disease Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Shrimps Disease Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Shrimps Disease Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Shrimps Disease Diagnostic Market Size by Country
10.4.1 Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 HiMedia Laboratories
11.1.1 HiMedia Laboratories Company Details
11.1.2 HiMedia Laboratories Business Overview
11.1.3 HiMedia Laboratories Shrimps Disease Diagnostic Introduction
11.1.4 HiMedia Laboratories Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.1.5 HiMedia Laboratories Recent Development
11.2 Speedy Assay Sdn Bhd
11.2.1 Speedy Assay Sdn Bhd Company Details
11.2.2 Speedy Assay Sdn Bhd Business Overview
11.2.3 Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Introduction
11.2.4 Speedy Assay Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.2.5 Speedy Assay Sdn Bhd Recent Development
11.3 REAGEN LLC
11.3.1 REAGEN LLC Company Details
11.3.2 REAGEN LLC Business Overview
11.3.3 REAGEN LLC Shrimps Disease Diagnostic Introduction
11.3.4 REAGEN LLC Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.3.5 REAGEN LLC Recent Development
11.4 FUJIKURA KASEI CO., LTD
11.4.1 FUJIKURA KASEI CO., LTD Company Details
11.4.2 FUJIKURA KASEI CO., LTD Business Overview
11.4.3 FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Introduction
11.4.4 FUJIKURA KASEI CO., LTD Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.4.5 FUJIKURA KASEI CO., LTD Recent Development
11.5 GeneReach Biotechnology Corp
11.5.1 GeneReach Biotechnology Corp Company Details
11.5.2 GeneReach Biotechnology Corp Business Overview
11.5.3 GeneReach Biotechnology Corp Shrimps Disease Diagnostic Introduction
11.5.4 GeneReach Biotechnology Corp Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.5.5 GeneReach Biotechnology Corp Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Shrimps Disease Diagnostic Introduction
11.6.4 Thermo Fisher Scientific Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Lab – Ind Resource Sdn Bhd
11.7.1 Lab – Ind Resource Sdn Bhd Company Details
11.7.2 Lab – Ind Resource Sdn Bhd Business Overview
11.7.3 Lab – Ind Resource Sdn Bhd Shrimps Disease Diagnostic Introduction
11.7.4 Lab – Ind Resource Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.7.5 Lab – Ind Resource Sdn Bhd Recent Development
11.8 AquaBounty Technologies, Inc
11.8.1 AquaBounty Technologies, Inc Company Details
11.8.2 AquaBounty Technologies, Inc Business Overview
11.8.3 AquaBounty Technologies, Inc Shrimps Disease Diagnostic Introduction
11.8.4 AquaBounty Technologies, Inc Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.8.5 AquaBounty Technologies, Inc Recent Development
11.9 pop bio
11.9.1 pop bio Company Details
11.9.2 pop bio Business Overview
11.9.3 pop bio Shrimps Disease Diagnostic Introduction
11.9.4 pop bio Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.9.5 pop bio Recent Development
11.10 SUREBIO
11.10.1 SUREBIO Company Details
11.10.2 SUREBIO Business Overview
11.10.3 SUREBIO Shrimps Disease Diagnostic Introduction
11.10.4 SUREBIO Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.10.5 SUREBIO Recent Development
11.11 Auro Biotechnologies
11.11.1 Auro Biotechnologies Company Details
11.11.2 Auro Biotechnologies Business Overview
11.11.3 Auro Biotechnologies Shrimps Disease Diagnostic Introduction
11.11.4 Auro Biotechnologies Revenue in Shrimps Disease Diagnostic Business (2016-2021)
11.11.5 Auro Biotechnologies Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Shrimps Disease Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of WSSV (White Spot Syndrome Virus)
Table 3. Key Players of TSV (Taura Syndrome Virus)
Table 4. Key Players of YHV/GAV (Yellow Head/Gill Associated Virus)
Table 5. Key Players of IHHNV (Infectious Hypodermal and Hematopoietic Virus)
Table 6. Key Players of HPV (Hepatopancreatic Parvovirus)
Table 7. Key Players of MBV (Monodon Baculovirus)
Table 8. Key Players of IMNV (Infectious Myonecrosis Virus)
Table 9. Key Players of NHP-B (Necrotising Hepatopancreatitis Bacteria)
Table 10. Key Players of MoV (Mourilyan Virus)
Table 11. Key Players of Early Mortality Syndrome (EMS)
Table 12. Global Shrimps Disease Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Shrimps Disease Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 14. Global Shrimps Disease Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 15. Global Shrimps Disease Diagnostic Market Share by Regions (2016-2021)
Table 16. Global Shrimps Disease Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 17. Global Shrimps Disease Diagnostic Market Share by Regions (2022-2027)
Table 18. Shrimps Disease Diagnostic Market Trends
Table 19. Shrimps Disease Diagnostic Market Drivers
Table 20. Shrimps Disease Diagnostic Market Challenges
Table 21. Shrimps Disease Diagnostic Market Restraints
Table 22. Global Shrimps Disease Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 23. Global Shrimps Disease Diagnostic Market Share by Players (2016-2021)
Table 24. Global Top Shrimps Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Shrimps Disease Diagnostic as of 2020)
Table 25. Ranking of Global Top Shrimps Disease Diagnostic Companies by Revenue (US$ Million) in 2020
Table 26. Global 5 Largest Players Market Share by Shrimps Disease Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Shrimps Disease Diagnostic Product Solution and Service
Table 29. Date of Enter into Shrimps Disease Diagnostic Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Shrimps Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 32. Global Shrimps Disease Diagnostic Revenue Market Share by Type (2016-2021)
Table 33. Global Shrimps Disease Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 34. Global Shrimps Disease Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 35. Global Shrimps Disease Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 36. Global Shrimps Disease Diagnostic Revenue Market Share by Application (2016-2021)
Table 37. Global Shrimps Disease Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 38. Global Shrimps Disease Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 39. North America Shrimps Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 40. North America Shrimps Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 41. North America Shrimps Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 42. North America Shrimps Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 43. North America Shrimps Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 44. North America Shrimps Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Europe Shrimps Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 46. Europe Shrimps Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Europe Shrimps Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 48. Europe Shrimps Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Europe Shrimps Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 50. Europe Shrimps Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Shrimps Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 52. Asia-Pacific Shrimps Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Shrimps Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 54. Asia-Pacific Shrimps Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 56. Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 57. Latin America Shrimps Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 58. Latin America Shrimps Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Latin America Shrimps Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 60. Latin America Shrimps Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Latin America Shrimps Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Latin America Shrimps Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Shrimps Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 64. Middle East & Africa Shrimps Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Shrimps Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 66. Middle East & Africa Shrimps Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 67. Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 68. Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 69. HiMedia Laboratories Company Details
Table 70. HiMedia Laboratories Business Overview
Table 71. HiMedia Laboratories Shrimps Disease Diagnostic Product
Table 72. HiMedia Laboratories Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 73. HiMedia Laboratories Recent Development
Table 74. Speedy Assay Sdn Bhd Company Details
Table 75. Speedy Assay Sdn Bhd Business Overview
Table 76. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Product
Table 77. Speedy Assay Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 78. Speedy Assay Sdn Bhd Recent Development
Table 79. REAGEN LLC Company Details
Table 80. REAGEN LLC Business Overview
Table 81. REAGEN LLC Shrimps Disease Diagnostic Product
Table 82. REAGEN LLC Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 83. REAGEN LLC Recent Development
Table 84. FUJIKURA KASEI CO., LTD Company Details
Table 85. FUJIKURA KASEI CO., LTD Business Overview
Table 86. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Product
Table 87. FUJIKURA KASEI CO., LTD Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 88. FUJIKURA KASEI CO., LTD Recent Development
Table 89. GeneReach Biotechnology Corp Company Details
Table 90. GeneReach Biotechnology Corp Business Overview
Table 91. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Product
Table 92. GeneReach Biotechnology Corp Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 93. GeneReach Biotechnology Corp Recent Development
Table 94. Thermo Fisher Scientific Company Details
Table 95. Thermo Fisher Scientific Business Overview
Table 96. Thermo Fisher Scientific Shrimps Disease Diagnostic Product
Table 97. Thermo Fisher Scientific Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 98. Thermo Fisher Scientific Recent Development
Table 99. Lab - Ind Resource Sdn Bhd Company Details
Table 100. Lab - Ind Resource Sdn Bhd Business Overview
Table 101. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Product
Table 102. Lab - Ind Resource Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 103. Lab - Ind Resource Sdn Bhd Recent Development
Table 104. AquaBounty Technologies, Inc Company Details
Table 105. AquaBounty Technologies, Inc Business Overview
Table 106. AquaBounty Technologies, Inc Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 107. AquaBounty Technologies, Inc Recent Development
Table 108. pop bio Company Details
Table 109. pop bio Business Overview
Table 110. pop bio Shrimps Disease Diagnostic Product
Table 111. pop bio Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 112. pop bio Recent Development
Table 113. SUREBIO Company Details
Table 114. SUREBIO Business Overview
Table 115. SUREBIO Shrimps Disease Diagnostic Product
Table 116. SUREBIO Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 117. SUREBIO Recent Development
Table 118. Auro Biotechnologies Company Details
Table 119. Auro Biotechnologies Business Overview
Table 120. Auro Biotechnologies Shrimps Disease Diagnostic Product
Table 121. Auro Biotechnologies Revenue in Shrimps Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 122. Auro Biotechnologies Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Shrimps Disease Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. WSSV (White Spot Syndrome Virus) Features
Figure 3. TSV (Taura Syndrome Virus) Features
Figure 4. YHV/GAV (Yellow Head/Gill Associated Virus) Features
Figure 5. IHHNV (Infectious Hypodermal and Hematopoietic Virus) Features
Figure 6. HPV (Hepatopancreatic Parvovirus) Features
Figure 7. MBV (Monodon Baculovirus) Features
Figure 8. IMNV (Infectious Myonecrosis Virus) Features
Figure 9. NHP-B (Necrotising Hepatopancreatitis Bacteria) Features
Figure 10. MoV (Mourilyan Virus) Features
Figure 11. Early Mortality Syndrome (EMS) Features
Figure 12. Global Shrimps Disease Diagnostic Market Share by Application: 2020 VS 2027
Figure 13. Fisheries Case Studies
Figure 14. Aquaculture Laboratories Case Studies
Figure 15. Marine Laboratories Case Studies
Figure 16. Education and Research Institutes Case Studies
Figure 17. Others Case Studies
Figure 18. Shrimps Disease Diagnostic Report Years Considered
Figure 19. Global Shrimps Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 20. Global Shrimps Disease Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 21. Global Shrimps Disease Diagnostic Market Share by Regions: 2020 VS 2027
Figure 22. Global Shrimps Disease Diagnostic Market Share by Regions (2022-2027)
Figure 23. Global Shrimps Disease Diagnostic Market Share by Players in 2020
Figure 24. Global Top Shrimps Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Shrimps Disease Diagnostic as of 2020
Figure 25. The Top 10 and 5 Players Market Share by Shrimps Disease Diagnostic Revenue in 2020
Figure 26. Global Shrimps Disease Diagnostic Revenue Market Share by Type (2016-2021)
Figure 27. Global Shrimps Disease Diagnostic Revenue Market Share by Type (2022-2027)
Figure 28. North America Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. North America Shrimps Disease Diagnostic Market Share by Type (2016-2027)
Figure 30. North America Shrimps Disease Diagnostic Market Share by Application (2016-2027)
Figure 31. North America Shrimps Disease Diagnostic Market Share by Country (2016-2027)
Figure 32. United States Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Canada Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Europe Shrimps Disease Diagnostic Market Share by Type (2016-2027)
Figure 36. Europe Shrimps Disease Diagnostic Market Share by Application (2016-2027)
Figure 37. Europe Shrimps Disease Diagnostic Market Share by Country (2016-2027)
Figure 38. Germany Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. France Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. U.K. Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Italy Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Russia Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Nordic Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Asia-Pacific Shrimps Disease Diagnostic Market Share by Type (2016-2027)
Figure 46. Asia-Pacific Shrimps Disease Diagnostic Market Share by Application (2016-2027)
Figure 47. Asia-Pacific Shrimps Disease Diagnostic Market Share by Region (2016-2027)
Figure 48. China Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Japan Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. South Korea Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Southeast Asia Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. India Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Australia Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Latin America Shrimps Disease Diagnostic Market Share by Type (2016-2027)
Figure 56. Latin America Shrimps Disease Diagnostic Market Share by Application (2016-2027)
Figure 57. Latin America Shrimps Disease Diagnostic Market Share by Country (2016-2027)
Figure 58. Mexico Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Brazil Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Middle East & Africa Shrimps Disease Diagnostic Market Share by Type (2016-2027)
Figure 62. Middle East & Africa Shrimps Disease Diagnostic Market Share by Application (2016-2027)
Figure 63. Middle East & Africa Shrimps Disease Diagnostic Market Share by Country (2016-2027)
Figure 64. Turkey Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Saudi Arabia Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. UAE Shrimps Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 67. HiMedia Laboratories Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 68. Speedy Assay Sdn Bhd Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 69. REAGEN LLC Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 70. FUJIKURA KASEI CO., LTD Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 71. GeneReach Biotechnology Corp Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 72. Thermo Fisher Scientific Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 73. Lab - Ind Resource Sdn Bhd Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 74. AquaBounty Technologies, Inc Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 75. pop bio Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 76. SUREBIO Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 77. Auro Biotechnologies Revenue Growth Rate in Shrimps Disease Diagnostic Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
世界のウエストナイルウイルス検査市場規模・現状・予測（2021年-2027年） West Nile virus is a tropical and temperate virus. It mainly infects birds, but also humans, horses, cats, skunks, gray rats, and domestic rabbits. The main route of transmission in humans is the bite of an infected mosquito. Market Analysis and Insights: Global West Nile Virus Testing Market The gl…- 世界の呼吸器合胞体ウイルス（RSV）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Syncytial Virus(RSV) Therapeutics Market The global Respiratory Syncytial Virus(RSV) Therapeutics market size is projected to reach US$ 837.5 million by 2027, from US$ 564.7 million in 2020, at a CAGR of 5.7% during 2021-2027. With industry-standard a…
- 世界のヒト免疫不全ウイルス (HIV) 治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Immunodeficiency Virus (HIV) Therapeutics Market The global Human Immunodeficiency Virus (HIV) Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…
- 世界のジカウイルス感染治療薬市場規模・現状・予測（2021年-2027年） It is used to treat various uncomfortable symptoms caused by zika virus infection. Market Analysis and Insights: Global Zika Virus Infection Drug Market The global Zika Virus Infection Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during…
- C型肝炎ウイルスエンベロープタンパク質E2のグローバル市場調査 2019年 The global Hepatitis C Virus Envelope Protein E2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hepatitis C Virus Envelope Protein E2 volume and value at global level, regional level and company le…